Literature DB >> 25171447

Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.

Tina S Ipe1, Jennifer J Wilkes, Helge D Hartung, Connie M Westhoff, Stella T Chou, David F Friedman.   

Abstract

A 5-year-old male with sickle cell disease presented with pain, dark urine, and fatigue 10 days after a red blood cell (RBC) transfusion. Laboratory evaluation demonstrated severe anemia, blood type O+, and anti-D in the serum. Anti-D in a D+ patient led to RH genotyping, which revealed homozygosity for RHD*DAU4 that encodes partial D antigen. Anti-D in this patient whose RBCs exclusively express partial D caused a delayed hemolytic transfusion reaction after exposure to D+ RBCs. The finding of anti-D in a D+patient should be investigated by molecular methods to help distinguish an alloantibody from an autoantibody.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25171447      PMCID： PMC4333075          DOI： 10.1097/MPH.0000000000000241

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


  13 in total

Review 1.  Indications and complications of transfusions in sickle cell disease.

Authors:  Kim Smith-Whitley; Alexis A Thompson
Journal:  Pediatr Blood Cancer       Date:  2012-05-04       Impact factor: 3.167

2.  Frequency of partial D phenotypes in the south western region of France.

Authors:  F Roubinet; P A Apoil; A Blancher
Journal:  Transfus Clin Biol       Date:  1996       Impact factor: 1.406

3.  Alloimmunization in sickle cell anemia in the era of extended red cell typing.

Authors:  Chibuzo O'Suoji; Robert I Liem; A Kyle Mack; Paris Kingsberry; Glenn Ramsey; Alexis A Thompson
Journal:  Pediatr Blood Cancer       Date:  2013-03-18       Impact factor: 3.167

4.  Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Authors:  Scott T Miller; Hae-Young Kim; Debra L Weiner; Carrie G Wager; Dianne Gallagher; Lori A Styles; Carlton D Dampier; Susan D Roseff
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

5.  Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Authors:  Julie-An M Talano; Cheryl A Hillery; Jerome L Gottschall; Diane M Baylerian; J Paul Scott
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

6.  The DAU allele cluster of the RHD gene.

Authors:  Franz F Wagner; Birgit Ladewig; Katharina S Angert; Guido A Heymann; Nicole I Eicher; Willy A Flegel
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

7.  Positive direct antiglobulin test in normal individuals.

Authors:  D W Gorst; V I Rawlinson; A H Merry; F Stratton
Journal:  Vox Sang       Date:  1980-02       Impact factor: 2.144

Review 8.  The direct antiglobulin test: a critical step in the evaluation of hemolysis.

Authors:  Nicole D Zantek; Scott A Koepsell; Daryl R Tharp; Claudia S Cohn
Journal:  Am J Hematol       Date:  2012-05-06       Impact factor: 10.047

9.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Authors:  Marion E Reid; Christine Halter Hipsky; Kim Hue-Roye; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2013-12-02       Impact factor: 3.039

10.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113
View more
  6 in total

1.  The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens.

Authors:  Kshitij Srivastava; Helene Polin; Sherry Lynne Sheldon; Franz Friedrich Wagner; Christoph Grabmer; Christian Gabriel; Gregory Andrew Denomme; Willy Albert Flegel
Journal:  Transfusion       Date:  2016-08-02       Impact factor: 3.157

Review 2.  Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Authors:  Eric A Gehrie; Paul M Ness; Evan M Bloch; Seema Kacker; Aaron A R Tobian
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

Review 3.  Application of genomics for transfusion therapy in sickle cell anemia.

Authors:  Stella T Chou; Connie M Westhoff
Journal:  Blood Cells Mol Dis       Date:  2017-08-08       Impact factor: 3.039

4.  American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Authors:  Stella T Chou; Mouaz Alsawas; Ross M Fasano; Joshua J Field; Jeanne E Hendrickson; Jo Howard; Michelle Kameka; Janet L Kwiatkowski; France Pirenne; Patricia A Shi; Sean R Stowell; Swee Lay Thein; Connie M Westhoff; Trisha E Wong; Elie A Akl
Journal:  Blood Adv       Date:  2020-01-28

5.  Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso.

Authors:  Koumpingnin Nebie; Salam Sawadogo; Salifo Sawadogo; Jérôme Koulidiati; Habi Y A Lengani; Abdoul G Sawadogo; Jérôme Babinet; Mohammed Khalloufi; Saliou Diop; Eléonore Kafando
Journal:  Afr J Lab Med       Date:  2022-09-26

6.  Delayed hemolytic transfusion reaction due to anti-D in Rh (D) positive patient.

Authors:  Deepti Sachan; Aswin S Kumar
Journal:  Asian J Transfus Sci       Date:  2016 Jul-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.